Terms: = Germ cell tumor AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Treatment
43 results:
1. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma.
McGowan E; Sanjak J; Mathé EA; Zhu Q
Orphanet J Rare Dis; 2023 Sep; 18(1):301. PubMed ID: 37749605
[TBL] [Abstract] [Full Text] [Related]
2. "More than a song and dance": Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok.
Morton M; Haight PJ; Khadraoui W; Backes F; Bixel K; O'Malley DM; Nagel C; Chambers LM
Gynecol Oncol; 2023 Aug; 175():81-87. PubMed ID: 37329872
[TBL] [Abstract] [Full Text] [Related]
3. Marital Status Independently Predicts Mortality in Adult Patients with Craniopharyngioma: A SEER-Based Study.
Pham J; Rhee B; Malpass R; Ozcan EE; Shaaya E; Doberstein C; Toms S; Sullivan P
World Neurosurg; 2023 Jul; 175():e367-e379. PubMed ID: 37003530
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry.
Jazmati D; Hero B; Thole-Kliesch TM; Merta J; Deubzer HE; Bäumer C; Heinzelmann F; Schleithoff SS; Koerber F; Eggert A; Schwarz R; Simon T; Timmermann B
Curr Oncol; 2022 Oct; 29(11):8222-8234. PubMed ID: 36354709
[TBL] [Abstract] [Full Text] [Related]
5. Malignant Gastrointestinal Neuroectodermal tumor: A New Kid on the Block?
Morani AC; Ramani NS; Yedururi S; Prasad SR
J Comput Assist Tomogr; 2022 Sep-Oct 01; 46(5):676-681. PubMed ID: 35759779
[TBL] [Abstract] [Full Text] [Related]
6. A Case Series of Metastatic Malignant Gastrointestinal Neuroectodermal tumors and Comprehensive Genomic Profiling Analysis of 20 Cases.
Kandler T; Cortez E; Clinton L; Hemmerich A; Ahmed O; Wong R; Forns T; MacNeill AJ; Hamilton TD; Khorasani M; Feng X
Curr Oncol; 2022 Feb; 29(2):1279-1297. PubMed ID: 35200608
[TBL] [Abstract] [Full Text] [Related]
7. Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review.
Parenrengi MA; Suryaningtyas W; Al Fauzi A; Hafid Bajamal A; Kusumastuti K; Utomo B; Muslim Hidayat Thamrin A; Sulistiono B
Cancer Control; 2022; 29():10732748211053927. PubMed ID: 35191733
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
[No Abstract] [Full Text] [Related]
9. Cost-Effectiveness of Temozolamide for treatment of Glioblastoma Multiforme in India.
Gupta N; Prinja S; Patil V; Bahuguna P
JCO Glob Oncol; 2021 Jan; 7():108-117. PubMed ID: 33449801
[TBL] [Abstract] [Full Text] [Related]
10. EIGHTEEN-MONTH RESULTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON VISION AND MICROCIRCULATION IN RADIATION MACULOPATHY.
Eandi CM; Polito MS; Schalenbourg A; Zografos L
Retina; 2021 Sep; 41(9):1883-1891. PubMed ID: 33411473
[TBL] [Abstract] [Full Text] [Related]
11. A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s.
Guaraldi F; Zoli M; Righi A; Gibertoni D; Marino Picciola V; Faustini-Fustini M; Morandi L; Bacci A; Pasquini E; Mazzatenta D; Asioli S
Clin Endocrinol (Oxf); 2020 Jul; 93(1):36-43. PubMed ID: 32306401
[TBL] [Abstract] [Full Text] [Related]
12. Personalized and targeted mutational analysis of multiple second primary melanomas under kinase inhibitors.
Donati M; Zelano G; Coppola R; Cinelli E; Verri M; Persichetti P; Perrella E; Devirgiliis V; Calvieri S; Crescenzi A; Panasiti V
Ital J Dermatol Venerol; 2021 Oct; 156(5):593-598. PubMed ID: 31804055
[TBL] [Abstract] [Full Text] [Related]
13. BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials.
Fujimura T; Hidaka T; Kambayashi Y; Aiba S
Expert Opin Investig Drugs; 2019 Feb; 28(2):143-148. PubMed ID: 30556435
[TBL] [Abstract] [Full Text] [Related]
14. Oral malignant gastrointestinal neuroectodermal tumour with junctional component mimicking mucosal melanoma.
Allanson BM; Weber MA; Jackett LA; Chan C; Lau L; Ziegler DS; Warby M; Mayoh C; Cowley MJ; Tucker KM; Long GV; Maher A; Anazodo A; Scolyer RA
Pathology; 2018 Oct; 50(6):648-653. PubMed ID: 30177220
[TBL] [Abstract] [Full Text] [Related]
15. Clear cell sarcoma of the gastrointestinal tract and malignant gastrointestinal neuroectodermal tumour: distinct or related entities? A review.
Green C; Spagnolo DV; Robbins PD; Fermoyle S; Wong DD
Pathology; 2018 Aug; 50(5):490-498. PubMed ID: 29970252
[TBL] [Abstract] [Full Text] [Related]
16. Ovarian masses in infant-juvenile age.
Sonmez K; Turkyilmaz Z; Karabulut R; Can Basaklar A
Arch Argent Pediatr; 2018 Jun; 116(3):e359-e364. PubMed ID: 29756706
[TBL] [Abstract] [Full Text] [Related]
17. First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA.
Broder MS; Cai B; Chang E; Yan T; Benson AB
J Med Econ; 2018 Aug; 21(8):821-826. PubMed ID: 29741466
[TBL] [Abstract] [Full Text] [Related]
18. Effect of tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
Stupp R; Taillibert S; Kanner A; Read W; Steinberg D; Lhermitte B; Toms S; Idbaih A; Ahluwalia MS; Fink K; Di Meco F; Lieberman F; Zhu JJ; Stragliotto G; Tran D; Brem S; Hottinger A; Kirson ED; Lavy-Shahaf G; Weinberg U; Kim CY; Paek SH; Nicholas G; Bruna J; Hirte H; Weller M; Palti Y; Hegi ME; Ram Z
JAMA; 2017 Dec; 318(23):2306-2316. PubMed ID: 29260225
[TBL] [Abstract] [Full Text] [Related]
19. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
Lawrie TA; Alazzam M; Tidy J; Hancock BW; Osborne R
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007102. PubMed ID: 27281496
[TBL] [Abstract] [Full Text] [Related]
20. Maintenance Therapy With tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
Stupp R; Taillibert S; Kanner AA; Kesari S; Steinberg DM; Toms SA; Taylor LP; Lieberman F; Silvani A; Fink KL; Barnett GH; Zhu JJ; Henson JW; Engelhard HH; Chen TC; Tran DD; Sroubek J; Tran ND; Hottinger AF; Landolfi J; Desai R; Caroli M; Kew Y; Honnorat J; Idbaih A; Kirson ED; Weinberg U; Palti Y; Hegi ME; Ram Z
JAMA; 2015 Dec; 314(23):2535-43. PubMed ID: 26670971
[TBL] [Abstract] [Full Text] [Related]
[Next]
